Cargando…
Proteomic profiling of bladder cancer for precision medicine in the clinical setting: A review for the busy urologist
At present, proteomic methods have successfully identified potential biomarkers of urological malignancies, such as prostate cancer (PC), bladder cancer (BC), and renal cell carcinoma (RCC), reflecting different numbers of key cellular processes, including extracellular environment modification, inv...
Autores principales: | Kim, Jayoung, Jin, Peng, Yang, Wei, Kim, Wun-Jae |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Urological Association
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7606121/ https://www.ncbi.nlm.nih.gov/pubmed/33135400 http://dx.doi.org/10.4111/icu.20200317 |
Ejemplares similares
-
Unmasking molecular profiles of bladder cancer
por: Piao, Xuan-Mei, et al.
Publicado: (2018) -
Era of the Fourth Industrial Revolution and the Urologists’ Journey to Navigating Big Omics Data
por: Kim, Jayoung
Publicado: (2018) -
The Urologist's View of Male Overactive Bladder: Discrepancy between Reality and Belief in Practical Setting
por: Lee, Seung Hwan, et al.
Publicado: (2010) -
Quick overview of diagnostic kits and smartphone apps for urologists during the COVID-19 pandemic: a narrative review
por: Park, Hyusim, et al.
Publicado: (2021) -
Are We Ready to Use the Omics Strategies for Precision Medicine?
por: Kim, Jayoung
Publicado: (2016)